Bibliographic information
GuidelineConsolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations
Year of Publication2022
Issuing InstitutionWHO
Recommendation
Maintained
Where HBV DNA is not available: Treatment may be considered based on persistently abnormal ALT levels alone, regardless of HBeAg status
Recommended in favor
Conditional
Certainty of evidence
Low
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
Year2015
InstitutionWorld Health Organization